Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Brian R. Moyer is active.

Publication


Featured researches published by Brian R. Moyer.


American Journal of Therapeutics | 1996

Biodistribution and autoradiographic localization of I-125--labeled synthetic Peptide in aortic atherosclerosis in cholesterol-fed rabbits.

Ping Lu; Pat Zanzonico; John Lister-James; Steven M. Goldfine; Edmund M. Herrold; Robert S. Lees; Ann M. Lees; Richard T. Dean; Brian R. Moyer; Jeffrey S. Borer

I-125-labeled SP4 is a synthetic oligopeptide derived from apolipoprotein B of low-density lipoprotein that has been shown to localize in atherosclerotic plaques in experimental animals. However, its biodistribution and mechanism of localization need to be further elucidated. Twenty-four cholesterol-fed (CF) and 20 normal (NL) New Zealand White rabbits were injected with I-125-SP4 and killed 15 to 30 min (6 NL; 6 CF) or 2 h (14 NL; 18 CF) later. We obtained aortic autoradiograms and activity concentrations (% injected dose/gin) in aortic segments and other tissues. The uptake of I-125-SP4 was higher in CF than in NL rabbits in all aortic segments (p < 0.05). I-125-SP4 was cleared rapidly in both CF and NL rabbits with 60 to 70% of the injected dose cleared from the blood by 1 h. No statistically significant differences in radiotracer biodistribution were observed between NL and CF rabbits although activity tended to be higher in the liver, gallbladder, and intestine in NL rabbits and in the kidney and spleen in CF rabbits. Silver grains were distributed mainly on foam cells of the fatty streaks in aortic microautoradiograms from two additional rabbits that had been injected with I-125-SP4. There were 23,518 ± 15,878 (SD) grains/mm2 in fatty plaques but only 14,669 ± 11,035 grains/mm2 in media muscle (p< 0.0001 [9 sections, 17 areas evaluated] in an atherosclerotic animal) in injected animals and 13,439 ± 5,565 grains/mm2 in media muscle (two sections, four areas) in the normal control animals (NS versus media of atherosclerotic animal). I-125-SP4 specifically localizes in aortic atherosclerotic plaques in CF rabbits. There is no significant difference in tissue distribution between normal and CF rabbits except in the aorta. Preliminarily, it appears that the site of tracer uptake is on foam cells and this suggests the possibility of relative specificity for fatty plaque.


Archive | 1983

Radionuclide and Nuclear Magnetic Resonance Methods of Evaluating Atherosclerosis

Thomas F. Budinger; Edward Ganz; David C. Price; Martin J. Lipton; Brian R. Moyer; Y. Yano; James B. Bassingthwaighte

Radionuclide techniques devoted to the evaluation of the atherosclerotic process have focused on measurements of function and metabolism of the heart and brain that might be affected by atherosclerosis, as well as on detection of thrombus formation in major arteries within and leading to these organs. This approach has more recently been joined by efforts to study the biochemical behavior of the arterial wall itself as well as the interaction of blood constituents with the components of the arteries. There is now sufficient basis to predict that we will be able to study facets of the atherosclerotic process in man using not only labeled platelets, labeled fibrin, and labeled lipoproteins, but labeled monoclonal antibodies to arterial wall constituents, fibrin, and lipoprotein receptor sites.


Archive | 1975

Effect of temperature on the latent track fading rate of AgC1 (cadmium doped) crystal detectors

John McGinnis; Ronald Cassou; Eugene V. Benton; Thomas F. Budinger; Brian R. Moyer

Author(s): McGinnis, John; Cassou, Ronald; Benton, Eugene V.; Budinger, Thomas; Moyer, Brian.


The Journal of Nuclear Medicine | 1996

Preclinical Evaluation of Technetium-99m-Labeled Somatostatin Receptor-Binding Peptides

Shankar Vallabhajosula; Brian R. Moyer; John Lister-James; Bill McBride; Helena Lipszyc; Hiram Lee; Diago Bastidas; R. T. Dean


Journal of Medicinal Chemistry | 1996

Somatostatin receptor-binding peptides labeled with technetium-99m: Chemistry and initial biological studies

Daniel A. Pearson; John Lister-James; William Mcbride; David M. Wilson; Lawrence J. Martel; Edgar R. Civitello; John E. Taylor; Brian R. Moyer; Richard T. Dean


Archive | 1993

TECHNETIUM-99m LABELED PEPTIDES FOR IMAGING INFLAMMATION

Richard T. Dean; Brian R. Moyer


The Journal of Nuclear Medicine | 1996

Thrombus Imaging with a Technetium-99m-Labeled, Activated Platelet Receptor-Binding Peptide

John Lister-James; Linda C. Knight; Alan H. Maurer; Larry R. Bush; Brian R. Moyer; Richard T. Dean


JAMA Internal Medicine | 2003

Imaging Characteristics of a Novel Technetium Tc 99m–Labeled Platelet Glycoprotein IIb/IIIa Receptor Antagonist in Patients With Acute Deep Vein Thrombosis or a History of Deep Vein Thrombosis

Shannon M. Bates; John Lister-James; Jim A. Julian; Raymond Taillefer; Brian R. Moyer; Jeffrey S. Ginsberg


The Journal of Nuclear Medicine | 1996

Technetium-99m-White Blood Cell-Specific Imaging Agent Developed from Platelet Factor 4 to Detect Infection

Brian R. Moyer; Shankar Vallabhajosula; John Lister-James; Larry R. Bush; John E. Cyr; Debra A. Snow; Diego Bastidas; Helena Lipszyc; R. T. Dean


The Journal of Nuclear Medicine | 1983

Labeled choline and phosphorylcholine: body distribution and brain autoradiography: concise communication.

Robert P. Friedland; Chester A. Mathis; Thomas F. Budinger; Brian R. Moyer; Mark A. Rosen

Collaboration


Dive into the Brian R. Moyer's collaboration.

Top Co-Authors

Avatar

Thomas F. Budinger

Lawrence Berkeley National Laboratory

View shared research outputs
Top Co-Authors

Avatar

John Lister-James

National Heart Foundation of Australia

View shared research outputs
Top Co-Authors

Avatar

R. T. Dean

National Heart Foundation of Australia

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Y. Yano

University of California

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Kathleen M. Brennan

Lawrence Berkeley National Laboratory

View shared research outputs
Top Co-Authors

Avatar

John Lister-James

National Heart Foundation of Australia

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge